SALT LAKE CITY--(BUSINESS WIRE)--Xlear has supplemented the numerous scientific studies it has already provided the Department of Justice and the Federal Trade Commission (FTC) in the government’s ...

A new nasal spray could soon offer Americans “fast-acting relief” from migraines and launch a new form of medicine onto the market, Pfizer announced on Thursday, touting promising results from late ...

The Food and Drug Administration on Friday approved Pfizer's nasal spray for migraines, giving patients access to a potentially fast-acting pain relief option. The drug, Zavzpret, also known as ...

Nathan Jones, CEO of Xlear, said that he feels that his company is emerging from the COVID-19 pandemic in better shape and is prepared to help retailers in the post-COVID era. He talked with Drug ...

At KPRC 2, we’re dedicated to keeping Houstonians informed. As part of our Ask 2 series, the newsroom will answer your questions about all things Houston. Answer: It’s unclear at this time and more ...